Katie Tarashuck, Vice President of Finance at Tune Therapeutics, attended as a partner representative. Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial ...

Novotech is a winner in the Diversity, Research and Development, and Marketing categories in the 2025 Pharmaceutical ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of Hepatitis B with a new, in-depth report.

Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial program advancing an epigenetic therapy with the potential to revolutionize the treatment landscape for ...

is proud to announce it has been awarded the Citeline CRO Partnership of the Year Award in recognition of its collaboration with Tune Therapeutics, a pioneering epigenetic editing company.

Katie Tarashuck, Vice President of Finance at Tune Therapeutics, attended as a partner representative. Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial program ...